Home > News > Three Decades From Now
August 3rd, 2008
Three Decades From Now
It takes 20 years, give or take, for a new technology to move through multiple cycles of development, commercialization, and competition necessary to evolve from experimental prototype to widespread maturity. A look back at the past few decades of medical progress suggests that 30 years is more likely in that field - there's one effect of regulation for you, a slowing of the technologies that manage to make it over the regulatory hurdle in the first place.
What does this pace of progress in medicine mean for middle-aged and younger people today? It means that the 2030s will see widespread, cost-effective use of the medical technologies you presently read about in the science press. A small selection:
* Replacement organs will be grown to order from your own cells.
* Stem cells will be created, manipulated, and transplanted to direct extraordinary regeneration
* Age-damaged immune systems will be wiped clean and replaced afresh.
* Gene therapy will be a mature technology, and genetic disorders curable.
* Everyone will know their DNA sequence, and have access to a vast database of knowledge that describes risks, therapies, and best practices.
* Cancer will be detected early, and even late-stage metastasis cured with few side-effects by nanoparticle-based, viral, or other therapies.
* The important mitochondrial DNA will be replaced when damaged by disease or age.
* Many of the biochemical processes underlying the benefits of exercise, calorie restriction, and known human longevity-associated genes will be reproduced by cheap drugs.
News and information
'Exotic' material is like a switch when super thin April 18th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014
Conductive Inks: booming to $2.8 billion by 2024 April 17th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
KEEP CALM and PUBLISH PAPERS – a new video blog with graphic tutorials to scientific publishing April 7th, 2014
Nanomaterials Improve Both the Anode and Cathode of Li-ion Batteries April 3rd, 2014
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
utsandiego.com November 22nd, 2012
Nanoparticles against aging October 3rd, 2012
Frost & Sullivan Hosts Webinar: Can We Live Forever? Gauging the Future Trajectory of Medical Technology Development March 24th, 2011